📰 Sofinnova Partners News
Page 6 - Sofinnova Partners News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Sofinnova Partners. Real-time updates on events, politics, business and more.
October 9, 2023
Additionally, the ASTM C423 sound absorption testing at the Johns Manville Technical Center in Colorado revealed that the bio-concrete demonstrated a Noise Reduction Coefficient (NRC) of 0.60, which indicates 60% sound absorption or 12 times that of traditional concrete, broadening the application of the innovative technology.
September 27, 2023
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
September 22, 2023
Rowan, known internally as ‘the professor’ is overseeing a massive strategy shift. Since he took charge in March 2021, the stock has jumped 89%.
September 14, 2023
Prometheus Materials has a solution for replacing one of the biggest contributors of greenhouse gasses, Microsofts financial backing and a plan to scale up quickly.
September 13, 2023
Roche Venture Fund joins existing major investors Epidarex Capital, Sofinnova Partners and BioGeneration Ventures September 13, 2023: Glasgow, Scotland...
September 13, 2023
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
September 8, 2023
Gradient Denervation Technologies announced that it closed a $15 million (€14 million) Series A financing round.
September 7, 2023
LONDON, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Myricx Bio (‘Myricx’), a UK biotech company focusing on the discovery and development of a completely novel...
September 7, 2023
Biocytogen Pharmaceuticals a global biotech company focusing on the discovery of novel antibody therapeutics today announces an antibody evaluation option and license agreement with Myricx Bio a UK biotech company focusing on the discovery and development of a completely novel class of selective cytotoxic payloads for antibody drug conjugates ADCs.
September 5, 2023
EQS-News: iOmx Therapeutics AG / Key word(s): PersonneliOmx Therapeutics appoints Dr. Nils Peter Debus as Chief Business Officer 05.09.2023 / 08:30 CET/CESTThe issuer is solely responsible for the content of this announcement.iOmx Therapeutics appoints Dr. Nils Peter Debus as Chief Business OfficerMartinsried / Muni...